BILIARY CEFPIRAMIDE EXCRETION - ITS RELATION TO BILIARY-EXCRETION OF BILE-ACIDS AND SULFOBROMOPHTHALEIN
Citation
H. Takikawa et al., BILIARY CEFPIRAMIDE EXCRETION - ITS RELATION TO BILIARY-EXCRETION OF BILE-ACIDS AND SULFOBROMOPHTHALEIN, Pharmacology, 51(1), 1995, pp. 24-32
Categorie Soggetti
Pharmacology & Pharmacy
SICI code
0031-7012(1995)51:1<24:BCE-IR>2.0.ZU;2-2
Abstract
Cefpiramide, a beta-lactam antibiotic, has been reported to be excrete
d from hepatocytes into the bile by a carrier-mediated system. Herein,
the relationship of biliary cefpiramide excretion to the excretion of
bile acids and sulfobromophthalein was studied in rats. Biliary cefpi
ramide excretion was markedly inhibited by sulfobromophthalein, lithoc
holate-3-O-glucuronide and taurolithocholate-3-sulfate, whereas it was
not inhibited by ursodeoxycholate or taurocholate. However, the inhib
itory effect of cefpiramide on the biliary excretion of sulfobromophth
alein or lithocholate-3-sulfate was very small. These findings indicat
e that, although cefpiramide is excreted by a process common to organi
c anions and bile acid sulfate and glucuronide, two or more excretory
pathways for organic anions exist and cefpiramide has affinity for onl
y one of these carriers.